Evaluation of the sample-to-result, random access NeuMoDx platform for viral load testing of Cytomegalovirus and Epstein Barr virus in clinical specimens
Authors:
Open Access
- 26 February 2022
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 149, 105122
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.Clinical Infectious Diseases, 2016
- Automated quantification of Epstein–Barr Virus in whole blood of hematopoietic stem cell transplant patients using the Abbott m2000 systemDiagnostic Microbiology and Infectious Disease, 2016
- Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelinesHaematologica, 2016
- Comparison of the Artus RotorGene and COBAS Ampliprep/COBAS TaqMan Platforms for the Detection of Cytomegalovirus: Experience of a Tertiary Care CenterGenetic Testing and Molecular Biomarkers, 2016
- Overview of Human Cytomegalovirus Pathogenesis2014
- Fully Automated Quantification of Cytomegalovirus (CMV) in Whole Blood with the New Sensitive Abbott RealTi m e CMV Assay in the Era of the CMV International StandardJournal of Clinical Microbiology, 2013
- How we treat cytomegalovirus in hematopoietic cell transplant recipientsBlood, 2009
- Comparison of two highly automated DNA extraction systems for quantifying Epstein–Barr virus in whole bloodJournal of Clinical Virology, 2008
- Validation of Clinical Application of Cytomegalovirus Plasma DNA Load Measurement and Definition of Treatment Criteria by Analysis of Correlation to Antigen DetectionJournal of Clinical Microbiology, 2004
- Epstein–Barr Virus InfectionNew England Journal of Medicine, 2000